Enrich Bioscience
PrivateLast Round
Grant
Jun 21, 2019
Total Funding Raised
$9,700
Company Overview
Enrich Bioscience operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Grant round in June 2019.
Enrich Bioscience is a biotechnology company that develops non-invasive, AI-powered PCR-based diagnostic solutions for early cancer detection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enrich Bioscience Comparables
Compare Enrich Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precision Epigenomics | 83% | |
| Epinoma | 82% | |
| Adela | 79% |
For institutional investors. Book with your work email.
Enrich Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 21, 2019 | ||||
| Accelerator | Sep 15, 2016 |
For institutional investors. Book with your work email.
Enrich Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Affairs Canada | Grant |
Enrich Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enrich Bioscience's valuation, stock price, and market status.
Is Enrich Bioscience a public or private company?
Enrich Bioscience is a private company.
What is the current stock price of Enrich Bioscience?
Enrich Bioscience is a private company, so its shares have no public market price. Caplight tracks Enrich Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enrich Bioscience worth (valuation)?
Valuation information for Enrich Bioscience is not publicly available.
Can I buy Enrich Bioscience stock?
Enrich Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enrich Bioscience's last funding round?
Enrich Bioscience's most recent funding round was Grant on June 21, 2019.
Who are the main investors in Enrich Bioscience?
Key investors in Enrich Bioscience include Global Affairs Canada.
Will Enrich Bioscience IPO soon?
No public IPO plans have been announced for Enrich Bioscience.
How can I track Enrich Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Enrich Bioscience's shares on secondary markets.